A Novel Benzenesulfonylurea-Substituted Pyridazinone Derivative with Antidiabetic Effect as the Peroxisome Proliferator-activated Receptor (PPAR-γ) Agonist. Valensi [Internet]. 2025 May 31 [cited 2025 Dec. 22];11(1):18-29. Available from: https://journal.uinjkt.ac.id/valensi/article/view/42187